Combination Chemotherapy in Treating Young Male Patients With Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer
cells, either by killing the cells or by stopping them from dividing. Giving combination
chemotherapy may kill more cancer cells.
PURPOSE: This phase II trial is studying the side effects and how well combination
chemotherapy works in treating young male patients with Hodgkin's lymphoma.